Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trial.

Pioglitazone、empagliflozin 與 glimepiride 作為第三線藥物用於 metformin 與 DPP-4 抑制劑控制不佳之第二型糖尿病患者的療效與安全性：多中心、第四期隨機對照試驗